GlassScriptPhysician profile
Aruna Pillai
NPI 1891742565
$6,521.81
in general payments reported to CMS, 2019-2025
37 companies · $1,200 in 2025
The $1,200 reported for 2025 was more than what 87% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,207 · 2020: $327 · 2021: $832 · 2022: $794 · 2023: $1,151 · 2024: $1,011 · 2025: $1,200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,362.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,362.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,110.98 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Amgen INC. | $873.38 | 2019-2025 | Evenity, Repatha, Otezla |
| Lilly USA, LLC | $576.66 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $576.26 | 2019-2025 | Farxiga, Airsupra |
| Pfizer INC. | $341.53 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $326.33 | 2022-2025 | |
| Glaxosmithkline, LLC. | $308.49 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Janssen Pharmaceuticals, INC | $269.93 | 2019-2023 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $240.03 | 2021-2025 | Jardiance, Synjardy |
| Astellas Pharma US INC | $226.22 | 2019-2024 | Veozah |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $195.36 | 2024-2025 | Caplyta |
| Abbvie INC. | $194.27 | 2021-2025 | |
| Abbott Laboratories | $170.16 | 2021-2024 | Freestyle Libre |
| E.R. Squibb & Sons, L.L.C. | $146.13 | 2019-2023 | Eliquis |
| Sanofi-Aventis U.S. LLC | $141.39 | 2022-2023 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Beta Bionics, INC. | $119.14 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $84.86 | 2019-2024 | Xifaxan, Trulance |
| Biohaven Pharmaceuticals, INC. | $65.32 | 2021 | |
| Dexcom, INC. | $55.75 | 2021-2023 | Dexcom G6 Transmitter |
| Novartis Pharmaceuticals Corporation | $54.22 | 2019-2023 | |
| Amarin Pharma, INC. | $49.30 | 2019-2020 | |
| Phathom Pharmaceuticals, INC. | $48.32 | 2024 | Voquezna |
| Otsuka America Pharmaceutical, INC. | $41.47 | 2024-2025 | Rexulti |
| Antares Pharma, INC. | $38.63 | 2024 | Xyosted |
| Halozyme INC | $30.72 | 2023 | |
| Esperion Therapeutics, INC. | $29.89 | 2025 | Nexletol |
| Indivior INC. | $29.05 | 2019 | |
| Aytu Biopharma, INC. | $28.36 | 2019 | |
| Titan Pharmaceuticals, INC. | $24.53 | 2019 | |
| Lundbeck LLC | $24.44 | 2023 | Rexulti |
| Vanda Pharmaceuticals INC. | $21.47 | 2025 | Fanapt |
| Exact Sciences Corporation | $14.56 | 2024 | Cologuard Collection Kit |
| Eisai INC. | $14.40 | 2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $13.53 | 2022 | |
| Allergan, INC. | $12.55 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $12.25 | 2019 | |
| Medtronic USA, INC. | $11.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aruna Pillai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.